CHIT1 and sarcoidosis: We also showed that CHIT1 significantly discriminated between active and under remission sarcoidosis disease as already reported [10], with a sensitivity and specificity of 96.9% (84.2–99.9) and 94.7% (74.099.9), respectively, and AUROC = 0.958 (0.862–0.994) (p < 0.001).